A Study to Evaluate Mesenchymal Stem Cell Product StromaForte's Effect on Cardiovascular Events

Clinical trial NCT06087848 · RECRUITING

Trial details

NCT number: NCT06087848
Sponsor: Cellcolabs Clinical LTD.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cardiovascular Diseases

Start date: 2023-10-07
Primary completion: 2029-10-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.